HeyJaredNeurotech Pulse
Stay informed on neurotech, brain-computer interfaces, and neuroscience breakthroughs. A one-stop read for all neuroscience researchers, founders, investors, and people excited about exploring the potential of the human brain.
- Indexed issues, last 90 days
- 5
- Latest publication
- Sep 15, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 15, 2026
Latest issues
#5 Neurotech Spotlight: The Scientists Who Built BCI's Evidence Base (opens the original)
Read excerpt
TL;DR: This edition traces four scientific foundations most BCI headlines stand on:Leigh Hochberg: the neurologist who’s been running the same clinical trial since before “BCI” was a category, and is still running it.Frank Guenther: the theorist whose model of how toddlers learn to talk is the scaffolding every speech-decoding pitch deck quietly stands on.Andrew Schwartz: the lab that had a paralyzed woman feeding herself with a robotic arm a decade before the rest of the field caught up to the
#41- Neurotech’s Momentum: FDA filings, Acquisitions, Reinvestments & the Infrastructure Catching Up. (opens the original)
Read excerpt
Welcome to Neurotech Pulse – Issue #41! The first half of August made one thing clear: neurotech’s commercial infrastructure is catching up to its science, with reimbursement, regulatory clearances, and balance sheets doing as much of the talking as new devices. Datasea secured FDA registration for its acoustic BCI biofeedback system, Ottobock expanded its neuro-orthotics footprint by acquiring a Spanish FES company, BrainsWay backs Radial Health with a strategic investment, and SoundHealth rais
#4 - Neurotech Spotlight: Origin, Infrastructure, & Regulatory firsts. (opens the original)
Read excerpt
TL;DR: This edition traces four layers of the same neurotech stack:Miguel Nicolelis - the man who coined “brain-machine interface” decades before it was a pitch deck. Marcus Gerhardt - the business co-founder whose hardware still powers a chunk of the field’s own research. Rajesh P. N. Rao - the lab asking a stranger question than most BCI companies bother with.Xu Honglai - the company that reached commercial approval first, from a country most western coverage wasn’t watching.<
#40 - Neurotech's Quiet Wins: Clearances, Partnerships, & the Paperwork That Builds (opens the original)
Read excerpt
Welcome to Neurotech Pulse – Issue #40! Not every month gets a headline implant or a nine-figure raise, sometimes the field just does its paperwork, and that’s the story this issue tells.VoxNeuro’s FDA clearance for its cfNI software, Amprion and Modality.AI’s diagnostic partnership, and Viz.ai’s move into neurodegenerative disease are the kind of unglamorous wins that quietly widen a device’s real-world reach. Meanwhile, a run of new research — on BCI recalibration, voice-synthesis decoding, an
Foundations, Dissent, & Distribution: Neurotech splits between the Lab, the Clinic, & the Consumer #3 (opens the original)
Read excerpt
TL;DR: In today's edition of Neuro Features, we're following one thread through neurotech — the lab that cracked the science, the founder who challenged the field's assumptions about implant safety, the operator who took a material nobody had tried in a human brain, and the device that never bothered with a clinic at all.The lab. Back in 2012, a UC Berkeley team taught a rat to fire a single cortical neuron on command, well enough to work a robotic reward lever. That's the finding modern BCI tra
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.